A new fight is brewing over the Medicare drug price negotiation program after the Trump administration proposed to consider ...

More medicines will be spared from Medicare price negotiations, a change that is projected to wipe out billions in savings ...

The pharmaceutical industry is criticizing the Trump administration’s plan for carrying out a critical round of Biden-era ...

The pharmaceutical industry is criticizing the Trump administration’s plan for carrying out a critical round of Medicare drug ...

The sweeping One Big Beautiful Bill Act, signed into federal law July 4, amended CMS’ drug price negotiations authority that could absolve nearly $5 billion in projected savings, according to the ...

Down here in Louisiana, we’ve got enough financial worries, especially after four years of Biden-induced inflation. Yet, ...

Adam Gray (D-CA), and Neal Dunn (R-FL) introduced the Protecting Patient Access to Cancer and Complex Therapies Act. This ...

Americans have been clamoring for sensible prescription drug reform for years. With the stroke of his pen, President Donald ...

President Donald Trump’s One Big Beautiful Bill, signed into law last week, reintroduces broader exemptions for orphan drugs ...

Americans have been clamoring for sensible prescription drug reform for years. With the stroke of his pen, President Donald ...

The House passed the “One Big Beautiful Bill Act” on July 3, which includes sweeping changes to healthcare and some pharma-related provisions.

The pharmaceutical industry’s lobbying muscle scored a high-stakes victory on Monday when the Senate parliamentarian reversed a previous decision and ruled that the Optimizing Research Progress Hope ...